Li Guanglie, Yang Shuai, Wang Siyang, Jiang Renwei, Xu Xiwei
Department of Head and Neck Oncology, The Fifth Hospital of Sun Yat-sen University, Zhuhai 519000, China.
Department of Radiotherapy Physics, The Fifth Hospital of Sun Yat-sen University, Zhuhai 519000, China.
Diagnostics (Basel). 2023 Jul 29;13(15):2530. doi: 10.3390/diagnostics13152530.
Dynamic F-FDG PET-CT scanning can accurately quantify F-FDG uptake and has been successfully applied in diagnosing and evaluating therapeutic effects in various malignant tumors. There is no conclusion as to whether it can accurately distinguish benign and malignant lymph nodes in nasopharyngeal cancer. The main purpose of this study is to reveal the diagnostic value of dynamic PET-CT in cervical lymph node metastasis of nasopharyngeal cancer through analysis.
We first searched for cervical lymph nodes interested in static PET-CT, measured their SUV-Max values, and found the corresponding lymph nodes in magnetic resonance images before and after treatment. The valid or invalid groups were included according to the changes in lymph node size before and after treatment. If the change in the product of the maximum diameter and maximum vertical transverse diameter of the lymph node before and after treatment was greater than or equal to 50%, they would be included in the valid group. If the change was less than 50%, they would be included in the invalid group. Their K values were measured on dynamic PET-CT and compared under different conditions. Then, we conducted a correlation analysis between various factors and K values. Finally, diagnostic tests were conducted to compare the sensitivity and specificity of K and SUV-Max.
We included 67 cervical lymph nodes from different regions of 51 nasopharyngeal cancer patients and divided them into valid and invalid groups based on changes before treatment. The valid group included 50 lymph nodes, while the invalid group included 17. There wer significant differences ( < 0.001) between the valid and the invalid groups in SUV-Max, K-Mean, and K-Max values. When the SUV-Max was ≤4.5, there was no significant difference in the K-Mean and K-Max between the two groups ( > 0.05). When the SUV-Max was ≤4.5 and pre-treatment lymph nodes were <1.0 cm, the valid group had significantly higher K-Mean (0.00910) and K-Maximum (0.01004) values than the invalid group (K-Mean = 0.00716, K-Max = 0.00767) ( < 0.05). When the SUV-Max was ≤4.5, the pre-treatment lymph nodes < 1.0 cm, and the EBV DNA replication normal, K-Mean (0.01060) and K-Max (0.01149) in the valid group were still significantly higher than the invalid group (K-Mean = 0.00670, K-Max = 0.00719) ( < 0.05). The correlation analysis between different factors (SUV-Max, T-stage, normal EB virus DNA replication, age, and pre-treatment lymph node < 1.0 cm) and the K value showed that SUV-Max and a pre-treatment lymph node < 1.0 cm were related to K-Mean and K-Max. Diagnostic testing was conducted; the AUC value of the SUV-Max value was 0.8259 (95% confidence interval: 0.7296-0.9222), the AUC value of the K-Mean was 0.8759 (95% confidence interval: 0.7950-0.9567), and the AUC value of the K-Max was 0.8859 (95% confidence interval: 0.8089-0.9629). After comparison, it was found that there was no significant difference in AUC values between K-Mean and SUV-Max ( = 0.220 > 0.05), and there was also no significant difference in AUC values between K max and SUV-Max ( = 0.159 > 0.05). By calculating the Youden index, we identified the optimal cut-off value. It was found that the sensitivity of SUV-Max was 100% and the specificity was 66%, the sensitivity of K-Mean was 100% and the specificity was 70%, and the sensitivity of K-Max was 100% and the specificity was 72%. After Chi-Square analysis, it was found that there was no significant difference in specificity between K-Mean and SUV-Max ( = 0.712), and there was also no significant difference in specificity between K-Max and SUV-Max ( = 0.755).
Dynamic PET-CT has shown a significant diagnostic value in diagnosing cervical lymph node metastasis of nasopharyngeal cancer, especially for the small SUV value, and lymph nodes do not meet the metastasis criteria before treatment, and EBV DNA replication is normal. Although the diagnostic accuracy, sensitivity, and specificity of dynamic PET-CT were not significantly different from traditional static PET-CT, the dynamic PET-CT had a more accurate tendency.
动态F-FDG PET-CT扫描能够准确量化F-FDG摄取情况,已成功应用于多种恶性肿瘤的诊断及治疗效果评估。对于其能否准确鉴别鼻咽癌颈部淋巴结的良恶性尚无定论。本研究的主要目的是通过分析揭示动态PET-CT在鼻咽癌颈部淋巴结转移诊断中的价值。
我们首先在静态PET-CT上寻找感兴趣的颈部淋巴结,测量其SUV-Max值,并在治疗前后的磁共振图像中找到相应淋巴结。根据治疗前后淋巴结大小的变化将其纳入有效或无效组。若淋巴结治疗前后最大直径与最大垂直横径乘积的变化大于或等于50%,则纳入有效组;若变化小于50%,则纳入无效组。在动态PET-CT上测量其K值,并在不同条件下进行比较。然后,对各因素与K值进行相关性分析。最后,进行诊断试验以比较K值和SUV-Max的敏感性和特异性。
我们纳入了51例鼻咽癌患者不同区域的67个颈部淋巴结,并根据治疗前的变化将其分为有效组和无效组。有效组包括50个淋巴结,无效组包括17个。有效组和无效组在SUV-Max、K均值和K最大值上存在显著差异(<0.001)。当SUV-Max≤4.5时,两组间的K均值和K最大值无显著差异(>0.05)。当SUV-Max≤4.5且治疗前淋巴结<1.0 cm时,有效组的K均值(0.00910)和K最大值(0.01004)显著高于无效组(K均值 = 0.00716,K最大值 = 0.00767)(<0.05)。当SUV-Max≤4.5、治疗前淋巴结<1.0 cm且EBV DNA复制正常时,有效组的K均值(0.01060)和K最大值(0.01149)仍显著高于无效组(K均值 = 0.00670,K最大值 = 0.00719)(<0.05)。对不同因素(SUV-Max、T分期、EB病毒DNA复制正常、年龄和治疗前淋巴结<1.0 cm)与K值进行相关性分析,结果显示SUV-Max和治疗前淋巴结<1.0 cm与K均值和K最大值相关。进行诊断试验;SUV-Max值的AUC值为0.8259(95%置信区间:0.7296 - 0.9222),K均值的AUC值为0.8759(95%置信区间:0.7950 - 0.9567),K最大值的AUC值为0.8859(95%置信区间:0.8089 - 0.9629)。比较后发现,K均值与SUV-Max的AUC值无显著差异(=0.220>0.05),K最大值与SUV-Max的AUC值也无显著差异(=0.159>0.05)。通过计算约登指数,我们确定了最佳截断值。结果发现,SUV-Max的敏感性为100%,特异性为66%,K均值的敏感性为100%,特异性为70%,K最大值的敏感性为100%,特异性为72%。经卡方分析发现,K均值与SUV-Max的特异性无显著差异(=0.712),K最大值与SUV-Max的特异性也无显著差异(=0.755)。
动态PET-CT在鼻咽癌颈部淋巴结转移诊断中显示出显著的诊断价值,尤其是对于SUV值较小、治疗前淋巴结不符合转移标准且EBV DNA复制正常的情况。虽然动态PET-CT的诊断准确性、敏感性和特异性与传统静态PET-CT无显著差异,但动态PET-CT有更准确的趋势。